A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 51/00 (2006.01) A61K 51/04 (2006.01) A61K 51/12 (2006.01)
Patent
CA 2158249
The present invention relates to novel radiopharmaceutical imaging agents having non-stannous reductants. Metallic compounds, such as Cu(I), Cu(II), Co(II), Fe(II), Sn(O), Zr(O), Cr(II) and Zn(O), will act to effectively reduce radionuclide containing solutions. Several non- metallic compounds, such as acids in general, dithionite, formamidine, formamadine sulfinic acid, phosphite, hypophosphite, dithiotreitol, hydrochloric acid, and borohydric acid may also be used to reduce radionuclide containing solutions. Moreover, it has been discovered that several agents, such as phosphines, sulfhydryl compounds, phosphites, thiols, thioethers, borates, borocyano groups, ascorbates and gentisates efficiently reduce radionuclide containing solutions and complex with the radionuclide at the same time. The present invention also relates to kits for forming radiopharmaceutical imaging agents, such kits including non-stannous reducing agents.
Brodack James W.
Derosch Mark A.
Deutsch Edward A.
Deutsch Karen F.
Dyszlewski Mary Marmion
Mallinckrodt Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
Radiopharmaceutical formulations having non-stannous reductants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiopharmaceutical formulations having non-stannous reductants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopharmaceutical formulations having non-stannous reductants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1615346